Avience Biomedicals Ltd

Avience Biomedicals Ltd IPO

Last updated:

Avience Biomedicals Ltd IPO Price Range is ₹196 - ₹208, with a minimum investment of ₹2,49,600 for 1200 shares per lot.

Subscription Rate

355.057x

as on 22 Jun 2026, 07:00PM IST

Minimum Investment

₹2,49,600

/ 1200 shares

IPO Status

Closed

Price Band

₹196 - ₹208

Bidding Dates

Jun 18, 2026 - Jun 22, 2026

Issue Size

₹30.24 Cr

Lot Size

600 shares

Min Investment

₹2,49,600

Listing Exchange

NSE

Avience Biomedicals Ltd IPO Application Timeline

passed
Open Date18 Jun 2026
passed
Close Date22 Jun 2026
passed
Allotment Date23 Jun 2026
passed
Listing Date25 Jun 2026

IPO Subscription Status

as on 22 Jun 2026, 07:00PM IST

IPO subscribed over

🚀 355.057x

This IPO has been subscribed by 401.357x in the retail category and 196.774x in the QIB category.

Subscription Rate

Total Subscription355.057x
Retail Individual Investors401.357x
Qualified Institutional Buyers196.774x
Non Institutional Investors427.766x

Strengths and Risks

Strengths

Strengths

  • Experienced Management Team and trained Employees.

  • Optimal Utilization of Resources.

  • Quality assurance and control.

  • Cordial relationships with our clients.


Risks

Risks

  • The pharmaceutical market is subject to extensive regulation and failures to comply with the existing and future regulatoryrequirements in any pharmaceutical market could expose its to litigation or other liabilities, which could adversely affectthe company reputation, business, financial condition and results of operations.

  • The company is dependent on certain customers for a portion of its revenues. The loss of any of its major customers dues to anyadverse development or significant reduction in business from its major customers may adversely affect the company business,financial condition, results of operations and future prospects.

  • The company relies on suppliers for medical devices and equipment manufacturers for its trading goods, and also faces risks in sourcingraw materials and components from third parties for the manufacturing and assembly of its medical equipment. Anydisruption in the supply of these goods or materials could adversely impact the company business, operations, and financial condition.

  • The company Financial Statement as Restated are prepared and signed by the Peer Review Auditor who is not Statutory Auditors ofits Company as required under the provisions of ICDR.

  • The company business derives a significant portion of its revenue from the trading sector, and any potential instability in this areacould pose a risk to the company overall performance.

  • The purchase and sale of medical devices and equipment for the company trading activities is significantly dependent on relatedparties.

  • Customer orders may experience delays, modifications, cancellations, or may not be fully paid, which could negativelyimpact the company business, financial condition, and operational results.

  • The company requires sizeable amounts of working capital for its continued operation and growth. The company inability to meet its workingcapital requirements could has a material adverse effect on the company business, results of operations and financial condition.

  • The company business depends on the efficient functioning of its manufacturing facilities and assembly units. Although the company has not received any product-related complaints, occasional machinery breakdowns in the past highlight the importance ofregular maintenance and operational enhancements. Any unforeseen obsolescence, damage, theft, or delays in repair couldhas an adverse impact on the company operations, cash flows, financial condition, and results.

  • The company import a portion of its raw material supply from China. Restrictions on or import duties relating to materials andequipment imported for the company manufacturing operations as well as restrictions on or import duties levied on its products inthe company export markets may adversely affect its business prospects, financial performance and cash flows.

How to Apply for Avience Biomedicals Ltd IPO on INDmoney

  1. Download the INDmoney app and complete your KYC.
  2. Go to INDstocks → IPO, or just search “IPO”.
  3. Tap on Avience Biomedicals Ltd IPO from the list of live IPOs.
  4. View key details like price band, lot size, and dates.
  5. Tap Apply Now and choose your number of lots.
  6. Use INDpay UPI for instant mandate tracking.
  7. Your funds will be blocked until the share allotment is finalized.

About Avience Biomedicals Ltd

Recognized under the Make in India Mission initiated by Prime Minister Narendra Modi, The Company commenced its journey by producing essential diagnostic kits like Viral Transport Media (VTM), Covid, HIV, HBs AG, Malaria, Dengue and others aimed at aiding medical institutions with affordable and good quality solutions.Avience Biomedicals has expanded its product range from IVD rapid test kits to include a comprehensive line of medical devices such as Serology products, Biochemistry Analyser and Biochemistry Reagents, showcasing a dedication to addressing various healthcare needs.

Frequently Asked Questions of Avience Biomedicals Ltd IPO

What is the size of the Avience Biomedicals Ltd IPO?

The size of the Avience Biomedicals Ltd IPO is ₹30.24 Cr.

What is the allotment date of the Avience Biomedicals Ltd IPO?

Avience Biomedicals Ltd IPO allotment date is Jun 23, 2026 (tentative).

What are the open and close dates of the Avience Biomedicals Ltd IPO?

The Avience Biomedicals Ltd IPO will open on Jun 18, 2026 and close on Jun 22, 2026

What is the lot size of Avience Biomedicals Ltd IPO?

The lot size for the Avience Biomedicals Ltd IPO is 600.

When will my Avience Biomedicals Ltd IPO order be placed?

Your Avience Biomedicals Ltd IPO order will be placed on Jun 18, 2026

Can we invest in Avience Biomedicals Ltd IPO?

Yes, once Avience Biomedicals Ltd IPO opens, you can invest in the shares of the company.

What would be the listing gains on the Avience Biomedicals Ltd IPO?

The potential listing gains on the Avience Biomedicals Ltd IPO will depend on various market factors and cannot be predicted with certainty.

What is 'pre-apply' for Avience Biomedicals Ltd IPO?

'Pre-apply' for Avience Biomedicals Ltd IPO indicates your interest in the IPO before it opens for subscription. This ensures quick application when the IPO goes live.